Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Tap1em1/Cya
Common Name:
Tap1-KO
Product ID:
S-KO-19084
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tap1-KO
Strain ID
KOCMP-21354-Tap1-B6J-VB
Gene Name
Tap1
Product ID
S-KO-19084
Gene Alias
ABC17; APT1; Abcb2; Ham-1; Ham1; MTP1; PSF1; RING4; TAP; Tap-1; Y3
Background
C57BL/6JCya
NCBI ID
21354
Modification
Conventional knockout
Chromosome
17
Phenotype
MGI:98483
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Tap1em1/Cya mice (Catalog S-KO-19084) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000170086
NCBI RefSeq
NM_013683
Target Region
Exon 4~5
Size of Effective Region
~1.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Tap1, also known as Antigen Peptide Transporter 1, is a member of the ATP-binding cassette (ABC) family. It is crucial for transporting antigen peptides from the cytoplasm to the lumen of the endoplasmic reticulum, and then loading them onto major histocompatibility complex (MHC) class I molecules, thus playing a significant role in the immune response and antigen presentation [5].

Tap1 has been associated with multiple diseases. In ankylosing spondylitis, specific polymorphisms in Tap1 (Tap1-333Val, Tap1-637Gly) were likely to be associated with the disease, especially when compared with HLA-B27-negative controls [1]. In uveal melanoma, upregulated Tap1 was associated with shorter survival, higher metastasis likelihood, and higher mortality, and in vitro silencing of Tap1 inhibited cell proliferation and metastasis [2]. In gastric cancer, Tap1 was identified as a T-cell related therapeutic target, and oxaliplatin could enhance immunotherapy by promoting Tap1 expression [3]. In colorectal cancer, down-regulation of Tap1 was a mechanism of tumor immune escape and a poor prognostic factor [4]. In pancreatic cancer, Tap1 promoted resistance to MEK inhibitors, and suppressing Tap1 sensitized resistant cells to the inhibitor [6]. In gastric carcinoma, TAP1 expression was positively correlated with various immunological traits and patients with high TAP1 expression were more likely to achieve complete remission after immunotherapy [5]. In locally advanced gastric cancer, high Tap1 expression was associated with better overall survival [7]. In a study with Apoe⁻/⁻Tap1⁻/⁻ mice, Tap1-deficiency did not alter atherosclerosis development, indicating a minor role for CD8⁺ T cells and Tap1-dependent antigen presentation in this disease process [8].

In conclusion, Tap1 is essential for antigen presentation and immune response. Studies, especially those using gene-knockout mouse models like Apoe⁻/⁻Tap1⁻/⁻ mice, have revealed its diverse roles in multiple diseases, including autoimmune diseases, cancers, and atherosclerosis. These findings contribute to a better understanding of disease mechanisms and may provide potential therapeutic targets.

References:
1. Qian, Yufeng, Wang, Genlin, Xue, Feng, Tang, Liang, Yang, Huilin. 2017. Genetic association between TAP1 and TAP2 polymorphisms and ankylosing spondylitis: a systematic review and meta-analysis. In Inflammation research : official journal of the European Histamine Research Society ... [et al.], 66, 653-661. doi:10.1007/s00011-017-1047-1. https://pubmed.ncbi.nlm.nih.gov/28405734/
2. Zhu, Ru, Chen, Yu-Ting, Wang, Bo-Wen, Jiang, Fa-Gang, Zhang, Ming-Chang. 2023. TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma. In BMC cancer, 23, 146. doi:10.1186/s12885-023-10527-9. https://pubmed.ncbi.nlm.nih.gov/36774490/
3. Zhao, Yupeng, Liu, Ziyuan, Deng, Kaiyuan, Li, Ranran, Xia, Jiazeng. 2024. Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy. In International immunopharmacology, 132, 111998. doi:10.1016/j.intimp.2024.111998. https://pubmed.ncbi.nlm.nih.gov/38593510/
4. Ling, Agnes, Löfgren-Burström, Anna, Larsson, Pär, Edin, Sofia, Palmqvist, Richard. 2017. TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer. In Oncoimmunology, 6, e1356143. doi:10.1080/2162402X.2017.1356143. https://pubmed.ncbi.nlm.nih.gov/29147604/
5. He, Zehua, Yang, Hong, Chen, Qingfeng, He, Wanrong, Chen, Zhihui. 2024. Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma. In Journal of gastrointestinal oncology, 15, 890-907. doi:10.21037/jgo-24-28. https://pubmed.ncbi.nlm.nih.gov/38989426/
6. Li, Boya, Feng, Yu, Hou, Qiaoyun, Fu, Yan, Luo, Yongzhang. 2022. Antigen Peptide Transporter 1 (TAP1) Promotes Resistance to MEK Inhibitors in Pancreatic Cancers. In International journal of molecular sciences, 23, . doi:10.3390/ijms23137168. https://pubmed.ncbi.nlm.nih.gov/35806187/
7. Segami, Kenki, Aoyama, Toru, Hiroshima, Yukihiko, Saeki, Hiroshi, Oshima, Takashi. . Clinical Significance of TAP1 and DLL4 Expression in Patients With Locally Advanced Gastric Cancer. In In vivo (Athens, Greece), 35, 2771-2777. doi:10.21873/invivo.12562. https://pubmed.ncbi.nlm.nih.gov/34410967/
8. Kolbus, Daniel, Ljungcrantz, Irena, Söderberg, Ingrid, Nilsson, Jan, Fredrikson, Gunilla Nordin. 2012. TAP1-deficiency does not alter atherosclerosis development in Apoe-/- mice. In PloS one, 7, e33932. doi:10.1371/journal.pone.0033932. https://pubmed.ncbi.nlm.nih.gov/22479479/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest